We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$307M
AUM Growth
-$18.2M
Cap. Flow
-$30.7M
Cap. Flow %
-9.98%
Top 10 Hldgs %
74.11%
Holding
84
New
23
Increased
11
Reduced
11
Closed
25

Sector Composition

Rank Sector Weight
1 Communication Services 49.4%
2 Technology 15.35%
3 Consumer Discretionary 3.99%
4 Industrials 3.7%
5 Healthcare 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZLTQ
26
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$1.83M 0.59%
80,770
+11,661
+17% +$231K
AGIO icon
27
Agios Pharmaceuticals
AGIO
$1.91B
$1.69M 0.55%
27,544
-264,357
-91% -$11.4M
CRTO icon
28
Criteo S.A. Ordinary Shares
CRTO
$1.09B
$1.42M 0.46%
+42,198
New +$1.38M
MCEP
29
DELISTED
Mid-Con Energy Partners, LP
MCEP
$1.39M 0.45%
3,154
+352
+13% +$159K
JWN
30
DELISTED
Nordstrom
JWN
$1.36M 0.44%
+19,831
New +$1.37M
PTLA
31
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.35M 0.44%
53,359
+3,599
+7% +$94.8K
BFH icon
32
Bread Financial
BFH
$4.4B
$1.33M 0.43%
6,673
AERI
33
DELISTED
Aerie Pharmaceuticals
AERI
$1.28M 0.42%
+62,080
New +$1.22M
SALE
34
DELISTED
RetailMeNot, Inc. Series 1
SALE
$774K 0.25%
47,899
TVRD
35
Tvardi Therapeutics
TVRD
$19.1M
$753K 0.25%
+2,492
New +$1.02M
PTCT icon
36
PTC Therapeutics
PTCT
$5.81B
$660K 0.21%
+15,000
New +$469K
XOOM
37
DELISTED
XOOM CORP COM
XOOM
$592K 0.19%
26,962
CTRL
38
DELISTED
Control4 Corporation
CTRL
$510K 0.17%
39,470
RKUS
39
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$506K 0.16%
37,887
-74,142
-66% -$968K
EPZM
40
DELISTED
Epizyme, Inc
EPZM
$460K 0.15%
+16,982
New +$528K
RCPT
41
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$456K 0.15%
+7,337
New +$351K
VSTM icon
42
Verastem
VSTM
$505M
$364K 0.12%
3,560
-1,667
-32% -$175K
CSLT
43
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$343K 0.11%
+26,498
New +$350K
SCOR icon
44
Comscore
SCOR
$111M
$338K 0.11%
464
-117
-20% -$88.4K
BIND
45
DELISTED
BIND THERAPEUTICS INC
BIND
$314K 0.1%
+36,500
New +$360K
INGN icon
46
Inogen
INGN
$168M
$300K 0.1%
+14,532
New +$295K
TSLA icon
47
Tesla
TSLA
$1.21T
$251K 0.08%
+15,540
New +$256K
ACHN
48
DELISTED
Achillion Pharmaceuticals
ACHN
$222K 0.07%
+22,202
New +$206K
HSTO
49
DELISTED
Histogen Inc. Common Stock
HSTO
$203K 0.07%
166
ETRM
50
DELISTED
EnteroMedics Inc.
ETRM
$136K 0.04%
+106
New +$155K

Similar funds

Hamilton Lane Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Hamilton Lane Advisors held 84 positions worth $307M, down 5.6% from $325M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Hamilton Lane Advisors withdrew a net $30.7M in Q3 2014, closing 25 positions and reducing 11 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $3.91M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 49% of assets, up from 48% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hamilton Lane Advisors opened a new position in Meta Platforms (Facebook) worth $21.8M.

  • Hamilton Lane Advisors's largest Q3 2014 buy was Meta Platforms (Facebook): 275,514 shares worth $21.8M.
  • Hamilton Lane Advisors added most to Shutterstock in Q3 2014, an estimated $9.24M increase.
  • Hamilton Lane Advisors's biggest Q3 2014 reduction was Twitter, Inc., cutting an estimated $59M.
  • Hamilton Lane Advisors fully exited IVERIC bio, Inc. Common Stock in Q3 2014, selling an estimated $3.91M.
  • Hamilton Lane Advisors's ten largest holdings make up 74% of its $307M portfolio in Q3 2014.
  • Hamilton Lane Advisors opened 23 new positions and closed 25 in Q3 2014.
  • Hamilton Lane Advisors's portfolio value fell 5.6% quarter-over-quarter to $307M.

Based on Hamilton Lane Advisors's 13F filing for Q3 2014, filed 6 Oct 2014.